Menu
/REGISTER
PPB
Fielding
Montecito
Powershare
Loading...
You are here:  Home  >  Health Care  -  Page 51

Montecito Bank & Trust
Latest

Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss

By   /  Monday, August 10th, 2015  /  Earnings, Health Care, Latest news, Tri-County Public Companies  /  Comments Off on Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss

Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2 million, compared to $19.5 million during the second quarter of 2014. On June 17, Allergan announced that it Read More →

Read More →
Latest

Dubroff: Washington dysfunction over taxes could cost jobs in Tri-Counties

By   /  Friday, August 7th, 2015  /  Columns, Health Care, Tri-County Economy  /  Comments Off on Dubroff: Washington dysfunction over taxes could cost jobs in Tri-Counties

This is a column about how dysfunction in Washington is handing billions over to Wall Street while threatening thousands of jobs on the Central Coast. Just a year ago, Allergan shut its Goleta breast implant operation after it came under siege from corporate raiders, Activis, a New Jersey-based company that used an acquisition in Ireland Read More →

Read More →
Latest

Shire makes $30 billion bid for Thousands Oaks’ Baxalta

By   /  Tuesday, August 4th, 2015  /  Health Care, Latest news, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Shire makes $30 billion bid for Thousands Oaks’ Baxalta

One of the biggest employers in Ventura County faces an ownership change less than one month after it was spun off from its Chicago-area parent. Shire Plc, a pharma company based in Dublin, Ireland, stunned the markets on Aug. 4 with a $30 billion bid for Baxalta. Baxalta, which employs around 2,000 at two locations Read More →

Read More →
Latest

Economic development should be part of Ventura County’s general plan

By   /  Friday, July 31st, 2015  /  Editorials, Health Care, Opinion  /  Comments Off on Economic development should be part of Ventura County’s general plan

Ventura County is embarking on an important step forward as it weighs the latest update to its general plan. That step would be to include an economic development element to the general plan in the next approval cycle. A letter to county officials from the Economic Development Collaborative of Ventura County recommends the county include Read More →

Read More →
Latest

Help Unlimited celebrates 40 years of pairing caregivers with patients

By   /  Friday, July 31st, 2015  /  Health Care, Small Business  /  Comments Off on Help Unlimited celebrates 40 years of pairing caregivers with patients

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

New Cancer Center of Santa Barbara aims for better collaboration

By   /  Friday, July 31st, 2015  /  Health Care, Latest news, Top Stories  /  Comments Off on New Cancer Center of Santa Barbara aims for better collaboration

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA approves Amgen’s Kyprolis

By   /  Friday, July 24th, 2015  /  East Ventura County, Health Care, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on FDA approves Amgen’s Kyprolis

The Food and Drug Administration approved Amgen’s Kyprolis for second-line treatments of multiple-myeloma on Friday. Thousand Oaks-based Amgen’s new treatment for multiple-myeloma could pay off big for the company now that the treatment can be accessed by more patients in the second line of treatments. Kyprolis was approved for third-line treatments in 2012. The FDA’s Read More →

Read More →